Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Kari Lynette Riggs
Introduction
Kari Lynette Riggs is a notable inventor based in Greenfield, IN (US). She has made significant contributions to the field of veterinary medicine through her innovative inventions. Her work focuses on improving the health and well-being of cats, particularly in the area of ectoparasitic control.
Latest Patents
Kari Lynette Riggs holds a patent for a single-dose oral formulation and methods for the treatment of cats with ectoparasiticidal spinosad. This invention provides a single-dose oral formulation of spinosad for the extended control of infestation on a cat at a predictable dose suitable for administration once every 30 days. The formulation is designed to enhance the ease of treatment for pet owners while ensuring effective control of parasites.
Career Highlights
Kari is associated with Eli Lilly and Company, where she has been able to leverage her expertise in pharmaceutical formulations. Her work has contributed to advancements in veterinary medicine, particularly in the development of effective treatments for common parasitic issues faced by cats.
Collaborations
Kari has collaborated with notable colleagues, including Daniel Earl Snyder and Michelle Leigh Totten. These collaborations have fostered a productive environment for innovation and have led to the successful development of her patented formulations.
Conclusion
Kari Lynette Riggs exemplifies the spirit of innovation in veterinary medicine through her groundbreaking work on spinosad formulations for cats. Her contributions not only enhance the quality of life for pets but also provide pet owners with effective solutions for parasite control.